Full-genome variant discovery across coding and non-coding regions. Ideal for population genomics, rare variant research, and structural variation analysis at maximum depth.
Ultra-deep analysis focused on protein-coding regions. Optimized for disease-focused research and clinical applications where cost-efficiency and depth are both critical.
Maximum-depth analysis for curated target gene sets. Optimized for oncology panels, pharmacogenomics, hereditary disease testing, and other specialty clinical applications.
The BioSpark team can design and deploy custom pipeline configurations for unique research requirements — including multi-omics integration, somatic calling, and joint cohort analysis.
Every BioSpark run produces fully standardized, reproducible outputs — ready for immediate downstream analysis or clinical review.
High-fidelity aligned read data processed against the current standard reference genome, with rigorous deduplication applied.
High-confidence identification deliverables rendered in universally accepted, industry-standard file formats.
Comprehensive quality assurance metrics including depth, density, and detailed performance statistics for every run.
The BioSpark engineering team works directly with early adopters to configure and extend the platform for specialized research requirements.